Page last updated: 2024-09-04

cilomilast and Bronchospasm

cilomilast has been researched along with Bronchospasm in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beume, R; Bundschuh, DS; Marx, D; Wohlsen, A; Wollin, L	1
Bochnowicz, S; Christensen, SB; Gorycki, PD; Hay, DW; Kotzer, CJ; Luttmann, MA; Osborn, RR; Torphy, TJ; Underwood, DC	1

Other Studies

2 other study(ies) available for cilomilast and Bronchospasm

Article	Year
Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors. Pulmonary pharmacology & therapeutics, 2006, Volume: 19, Issue:5 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Aminopyridines; Animals; Benzamides; Bronchial Spasm; Bronchoalveolar Lavage Fluid; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Disease Models, Animal; Immunization; Male; Neutrophils; Nitriles; Ovalbumin; Phosphodiesterase Inhibitors; Pneumonia; Pyridines; Rats; Respiratory Hypersensitivity; Rolipram; Serotonin; Treatment Outcome; Tumor Necrosis Factor-alpha	2006
Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:3 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Asthmatic Agents; Bronchial Spasm; Bronchoconstriction; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Enzyme Inhibitors; Guinea Pigs; Histamine; In Vitro Techniques; Leukotriene D4; Muscle Contraction; Nitriles; Ovalbumin; Trachea	1998

Article

Year

Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.

Pulmonary pharmacology & therapeutics, 2006, Volume: 19, Issue:5

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Aminopyridines; Animals; Benzamides; Bronchial Spasm; Bronchoalveolar Lavage Fluid; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Disease Models, Animal; Immunization; Male; Neutrophils; Nitriles; Ovalbumin; Phosphodiesterase Inhibitors; Pneumonia; Pyridines; Rats; Respiratory Hypersensitivity; Rolipram; Serotonin; Treatment Outcome; Tumor Necrosis Factor-alpha

2006

Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig.

The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:3

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Asthmatic Agents; Bronchial Spasm; Bronchoconstriction; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Enzyme Inhibitors; Guinea Pigs; Histamine; In Vitro Techniques; Leukotriene D4; Muscle Contraction; Nitriles; Ovalbumin; Trachea

1998